ALCLS:EPA
Cellectis SA
၁.၀၅ €
arrow_upward
+၁.၉၅%(+၀.၀၂၀) 1D
နို ၅, GMT+၁ ၁၇:၃၅:၀၄ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCLS...
Open
၁.၀၇ €
High
၁.၀၉ €
Low
၁.၀၁ €
Mkt. cap
၇.၀၄ ကုဋေ
Avg. vol.
၃.၃၄ သိန်း
Volume
၃.၃၇ သိန်း
52-wk high
၄.၇၅ €
52-wk low
၀.၉၀ €
EPS
-၀.၅၈ €
Shares outstanding
၇.၂၁ ကုဋေ
No. of employees
၂၂၇
Open
၁.၀၇ €
High
၁.၀၉ €
Low
၁.၀၁ €
Mkt. cap
၇.၀၄ ကုဋေ
Avg. vol.
၃.၃၄ သိန်း
Volume
၃.၃၇ သိန်း
52-wk high
၄.၇၅ €
52-wk low
၀.၉၀ €
EPS
-၀.၅၈ €
Shares outstanding
၇.၂၁ ကုဋေ
No. of employees
၂၂၇
News stories
From web sources and news partners
FinancialContent
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Figs’s (NYSE:FIGS) Q3 2026: strong sales, provides optimistic revenue guidance for next quarter
New York Post
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
Wall Street sees biggest market cap drops ever after midterm bloodbath for GOP
CNBC
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Nasdaq drops into correction territory — here’s what typically happens next
Fox Business
·
ပြီးခဲ့သည့် ၁ နာရီ
Stocks plunge as Dem midterm sweep fuels AI regulatory concerns
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA